- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 34.22M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $235.62M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $204.82M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $6.17M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $17.87M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $30.28M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $12.94M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $121.78M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $158.66M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $455.09M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $451.16M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $249.39M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $238M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $992.16M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $990.35M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 30.38M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $7.28M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$22.02M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $324.47M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $321.25M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.53 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.53 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $57.07M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$13.36M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.07M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $96.56M |
| Revenue | Q1 2025 · Mar 31, 2024 | $155.33M |